Literature DB >> 26054584

Systemic inflammation as a predictor of clinical outcomes after lower extremity angioplasty/stenting.

Kenneth DeSart1, Kerri O'Malley1, Bradley Schmit1, Maria-Cecilia Lopez2, Lyle Moldawer1, Henry Baker2, Scott Berceli3, Peter Nelson4.   

Abstract

OBJECTIVE: The activation state of the systemic inflammatory milieu has been proposed as a critical regulator of vascular repair after injury. We evaluated the early inflammatory response after endovascular intervention for symptomatic peripheral arterial disease to determine its association with clinical success or failure.
METHODS: Blood samples were obtained from 14 patients undergoing lower extremity angioplasty/stenting and analyzed using high-throughput gene arrays, multiplex serum protein analyses, and flow cytometry.
RESULTS: Time-dependent plasma protein and monocyte phenotype analyses demonstrated endovascular revascularization had a modest influence on the overall activation state of the systemic inflammatory system, with baseline variability exceeding the perturbations induced by the intervention. In contrast, specific time-dependent changes in the monocyte genome are evident in the initial 28 days, predominately in those genes associated with leukocyte extravasation. Investigating the relationship between inflammation and the 1-year success or failure of the intervention showed no single plasma protein was correlated with outcome, but a more comprehensive cluster analysis revealed a clear pattern of protein expression that was closely related to the clinical phenotype. Corresponding examination of the monocyte genome identified a gene subset at 1 day postprocedure that was predictive of clinical outcome, with most of these genes active in cell-cycle signaling.
CONCLUSIONS: Although the global influence of angioplasty/stenting on systemic inflammation was modest, circulating cytokine and monocyte genome analyses support a pattern of early inflammation that is associated with ultimate intervention success vs failure. Molecular profiles incorporating genes involved in monocyte cell-cycle progression and homing, or proinflammatory cytokines, or both, offer the most promise for the development of class prediction tools for clinical application. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26054584      PMCID: PMC4670612          DOI: 10.1016/j.jvs.2015.04.399

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  32 in total

1.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

2.  Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty.

Authors:  A Buffon; G Liuzzo; L M Biasucci; P Pasqualetti; V Ramazzotti; A G Rebuzzi; F Crea; A Maseri
Journal:  J Am Coll Cardiol       Date:  1999-11-01       Impact factor: 24.094

3.  C-reactive protein and brain natriuretic peptide as predictors of adverse events after lower extremity endovascular revascularization.

Authors:  Patrick A Stone; Haley Schlarb; John E Campbell; David Williams; Stephanie N Thompson; Molly John; James R Campbell; Ali F AbuRahma
Journal:  J Vasc Surg       Date:  2014-04-29       Impact factor: 4.268

4.  Systemic inflammation worsens outcomes in emergency surgical patients.

Authors:  Robert D Becher; J Jason Hoth; Preston R Miller; J Wayne Meredith; Michael C Chang
Journal:  J Trauma Acute Care Surg       Date:  2012-05       Impact factor: 3.313

5.  Development of a genomic metric that can be rapidly used to predict clinical outcome in severely injured trauma patients.

Authors:  Alex G Cuenca; Lori F Gentile; M Cecilia Lopez; Ricardo Ungaro; Huazhi Liu; Wenzhong Xiao; Junhee Seok; Michael N Mindrinos; Darwin Ang; Tezcan Ozrazgat Baslanti; Azra Bihorac; Philip A Efron; Joseph Cuschieri; H Shaw Warren; Ronald G Tompkins; Ronald V Maier; Henry V Baker; Lyle L Moldawer
Journal:  Crit Care Med       Date:  2013-05       Impact factor: 7.598

6.  The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans.

Authors:  Y M Fong; M A Marano; L L Moldawer; H Wei; S E Calvano; J S Kenney; A C Allison; A Cerami; G T Shires; S F Lowry
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

7.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

8.  Rationale and study design of the CardioGene Study: genomics of in-stent restenosis.

Authors:  Santhi K Ganesh; Kimberly A Skelding; Laxmi Mehta; Kathleen O'Neill; Jungnam Joo; Gang Zheng; James Goldstein; Robert Simari; Eric Billings; Nancy L Geller; David Holmes; William W O'Neill; Elizabeth G Nabel
Journal:  Pharmacogenomics       Date:  2004-10       Impact factor: 2.533

Review 9.  Mechanisms of intimal hyperplasia learned from a murine carotid artery ligation model.

Authors:  Le-Ning Zhang; John F Parkinson; Christopher Haskell; Yi-Xin Wang
Journal:  Curr Vasc Pharmacol       Date:  2008-01       Impact factor: 2.719

10.  Percutaneous transluminal angioplasty of lower limb arteries causes a systemic inflammatory response.

Authors:  Jitesh H Parmar; Mo Aslam; Nigel J Standfield
Journal:  Ann Vasc Surg       Date:  2009-05-21       Impact factor: 1.466

View more
  5 in total

1.  A predictive multiscale model of in-stent restenosis in femoral arteries: linking haemodynamics and gene expression with an agent-based model of cellular dynamics.

Authors:  Anna Corti; Monika Colombo; Jared M Rozowsky; Stefano Casarin; Yong He; Dario Carbonaro; Francesco Migliavacca; Jose F Rodriguez Matas; Scott A Berceli; Claudio Chiastra
Journal:  J R Soc Interface       Date:  2022-03-30       Impact factor: 4.118

Review 2.  Current and potential imaging applications of ferumoxytol for magnetic resonance imaging.

Authors:  Gerda B Toth; Csanad G Varallyay; Andrea Horvath; Mustafa R Bashir; Peter L Choyke; Heike E Daldrup-Link; Edit Dosa; John Paul Finn; Seymur Gahramanov; Mukesh Harisinghani; Iain Macdougall; Alexander Neuwelt; Shreyas S Vasanawala; Prakash Ambady; Ramon Barajas; Justin S Cetas; Jeremy Ciporen; Thomas J DeLoughery; Nancy D Doolittle; Rongwei Fu; John Grinstead; Alexander R Guimaraes; Bronwyn E Hamilton; Xin Li; Heather L McConnell; Leslie L Muldoon; Gary Nesbit; Joao P Netto; David Petterson; William D Rooney; Daniel Schwartz; Laszlo Szidonya; Edward A Neuwelt
Journal:  Kidney Int       Date:  2017-04-20       Impact factor: 10.612

3.  Anti-phosphorylcholine IgM, an Anti-inflammatory Mediator, Predicts Peripheral Vein Graft Failure: A Prospective Observational Study.

Authors:  Michael Sobel; Mayumi Yagi; Katherine Moreno; Ted R Kohler; Gale L Tang; Errol S Wijelath; Julieann Marshall; Richard D Kenagy
Journal:  Eur J Vasc Endovasc Surg       Date:  2018-10-19       Impact factor: 7.069

4.  Percutaneous Transluminal Angioplasty in Patients with Peripheral Arterial Disease Does Not Affect Circulating Monocyte Subpopulations.

Authors:  Pawel Maga; Tomasz P Mikolajczyk; Lukasz Partyka; Marek Krzanowski; Krzysztof P Malinowski; Rafal Nizankowski
Journal:  Biomed Res Int       Date:  2016-10-13       Impact factor: 3.411

5.  Prospective Validation of a Transcriptomic Metric in Severe Trauma.

Authors:  Steven L Raymond; Russell B Hawkins; Zhongkai Wang; Juan C Mira; Julie A Stortz; Feifei Han; Jennifer D Lanz; Laura V Hennessy; Babette A Brumback; Henry V Baker; Philip A Efron; Scott C Brakenridge; Wenzhong Xiao; Ronald G Tompkins; Joseph Cuschieri; Frederick A Moore; Ronald V Maier; Lyle L Moldawer
Journal:  Ann Surg       Date:  2020-05       Impact factor: 13.787

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.